L.A. Friedman
Impact in
- Obstetrics and Gynecology top 5%
- Pregnancy and preeclampsia studies
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 2
- Inflammatory mediators and NSAID effects 2
- Oncology 2
- Cancer Risks and Factors 1
- Drug Transport and Resistance Mechanisms 1
- Co-authors
- C.N. Hensby (3 shared papers)Penny Lewis (2 shared papers)Peter Boylan (1 shared paper)Petra J. Lewis (1 shared paper)I. Downing (1 shared paper)Garret A. FitzGerald (1 shared paper)John O’Grady (1 shared paper)Isamu Miyamori (1 shared paper)
- Journals
- Prostaglandins (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Life Sciences (1 paper)JNCI Journal of the National Cancer Institute (1 paper)BMJ (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
L.A. Friedman
5 papers receiving 338 citations
Peers
Comparison fields: 5 of 69
- Obstetrics and Gynecology 83
- Pharmacology 120
- Biochemistry 41
- Internal Medicine 15
- Cardiology and Cardiovascular Medicine 68
Countries citing papers authored by L.A. Friedman
This map shows the geographic impact of L.A. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.A. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.A. Friedman more than expected).
Fields of papers citing papers by L.A. Friedman
This network shows the impact of papers produced by L.A. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.A. Friedman. The network helps show where L.A. Friedman may publish in the future.
Co-authors
The 25 scholars most cited alongside L.A. Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 138 | |
| 2 | 1979 | 96 | |
| 3 | 2003 | 72 | |
| 4 | 1979 | 55 | |
| 5 | 1980 | 14 |
About L.A. Friedman
L.A. Friedman is a scholar working on Pharmacology, Oncology, Pharmacology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 5 papers that have together received 375 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Inflammatory mediators and NSAID effects (2 papers), Eicosanoids and Hypertension Pharmacology (1 paper), Hormonal and reproductive studies (1 paper), Antiplatelet Therapy and Cardiovascular Diseases (1 paper), Cancer Risks and Factors (1 paper), Drug Transport and Resistance Mechanisms (1 paper) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). The work is most often cited by research in Obstetrics and Gynecology (83 citations), Pharmacology (120 citations), Biochemistry (41 citations), Internal Medicine (15 citations) and Cardiology and Cardiovascular Medicine (68 citations). L.A. Friedman has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include C.N. Hensby, Penny Lewis, Peter Boylan, Petra J. Lewis, I. Downing, Garret A. FitzGerald, John O’Grady, Isamu Miyamori, C. T. Dollery and G A FitzGerald. Their work appears in journals such as Prostaglandins, Clinical Pharmacology & Therapeutics, Life Sciences, JNCI Journal of the National Cancer Institute and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.